外显子作为孤独症截短突变表型影响的功能单元
该研究分析孤独症谱系障碍(ASD)中截短突变与表型异质性的关系,发现影响同一外显子的截短突变常导致无关ASD先证者相似的智力表型,且该模式在两个独立先证者队列及多个ASD相关表型中重现。外显子而非基因常构成截短突变有效表型影响的单元,其机制可能由剪接异构体的无义介导衰变(NMD)介导,ASD表型常由整体基因剂量相对轻度(15-30%)下降触发。
要点
- 影响同一外显子的截短突变常导致无关ASD先证者相似的智力表型。
- 外显子而非基因常是截短突变有效表型影响的单元。
- ASD表型常由整体基因剂量相对轻度(15-30%)下降触发。
核心结论
- 外显子而非基因常代表孤独症中截短突变的有效表型影响单元。
- 观察到的表型模式可能由剪接异构体的无义介导衰变(NMD)介导。
- ASD表型常由整体基因剂量相对轻度(15-30%)下降触发。
研究设计与样本
- 研究分析ASD先证者中影响同一基因的LGD新发突变与表型异质性的关系。
- 研究在两个独立先证者队列中验证外显子水平截短突变与表型的关联模式。
主要发现
- 影响同一外显子的截短突变频繁导致无关ASD先证者 strikingly 相似的智力表型。
- 偏向产前表达的外显子优先贡献于较低IQ表型的ASD病例,偏向产后表达的外显子优先贡献于较高IQ表型的ASD病例。
- 每个具有复发突变的ASD基因可由表型剂量敏感性(PDS)参数表征,量化基因剂量变化与给定疾病表型变化的关系。
- 外显子LGD与多种人类组织中基因表达变化之间存在类似关系。
临床怎么用
- 解读ASD截短突变时需考虑外显子水平而非仅基因水平。
- 评估基因剂量下降程度(如15-30%)有助于理解ASD表型。
- PDS参数可用于量化基因剂量变化与疾病表型的关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autism spectrum disorders (ASD) are a group of related neurodevelopmental diseases displaying significant genetic and phenotypic heterogeneity. Despite recent progress in understanding ASD genetics, the nature of phenotypic heterogeneity across probands remains unclear. Notably, likely gene-disrupting (LGD) de novo mutations affecting the same gene often result in substantially different ASD phenotypes. Nevertheless, we find that truncating mutations affecting the same exon frequently lead to strikingly similar intellectual phenotypes in unrelated ASD probands. Analogous patterns are observed for two independent proband cohorts and several other important ASD-associated phenotypes. We find that exons biased toward prenatal and postnatal expression preferentially contribute to ASD cases with lower and higher IQ phenotypes, respectively. These results suggest that exons, rather than genes, often represent a unit of effective phenotypic impact for truncating mutations in autism. The observed phenotypic patterns are likely mediated by nonsense-mediated decay (NMD) of splicing isoforms, with autism phenotypes usually triggered by relatively mild (15-30%) decreases in overall gene dosage. We find that each ASD gene with recurrent mutations can be characterized by a parameter, phenotype dosage sensitivity (PDS), which quantifies the relationship between changes in a gene's dosage and changes in a given disease phenotype. We further demonstrate analogous relationships between exon LGDs and gene expression changes in multiple human tissues. Therefore, similar phenotypic patterns may be also observed in other human genetic disorders.
引用
- Chiang AH, Chang J, Wang J, et al. Exons as units of phenotypic impact for truncating mutations in autism. Mol Psychiatry. 2020. PMID: 33110259. doi:10.1038/s41380-020-00876-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。